• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Stephen Gandel

Stay informed with Stephen Gandel’s coverage and analysis for Coins2Day.

    Page 23 of 78

  • J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)Finance

    Here’s Why Valeant CEO Michael Pearson’s Stock Sale Matters

    By Contributing Writer
  • JPMorgan Chase & Co. Chief Executive Officer Jamie Dimon InterviewFinance

    Jamie Dimon: Don’t be so Damned Depressed

    By Investment Desk
  • Coins2Day Global Forum 2015Finance

    Jamie Dimon: Virtual Currency Will Be Stopped

    By Investment Desk
  • Coins2Day Global Forum 2015Finance

    What Bank Accounts and Toilets Can Teach Us About Corruption in India

    By Financial Writer
  • Satya Nadella Launches Microsoft Build ConferenceFinance

    Bond Market Rally: It’s Not Time for Economic Celebration Just Yet

    By Editorial Team
  • Finance

    Chart: Here’s what the U.S.’s largest companies are doing with their cash

    By Industry Analyst
  • J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, QuebecHealth

    Valeant: A timeline of the big Pharma scandal

    By Trading Desk
  • Hedge fund manager Bill AckmanFinance

    Bill Ackman on Valeant: ‘Life will go on’

    By Investment Desk
  • Pfizer And AstraZeneca's Billion Dollar BattleFinance

    Pfizer-Allergan could be a super inversion deal

    By Research Team
  • J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)Finance

    Valeant accounting scandal: 4 critical questions that have been left unanswered

    By News Correspondent
  • Hedge fund manager Bill AckmanFinance

    What the drop in Valeant’s stock says about hedge funds’ herd mentality

    By Industry Analyst
  • J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)Finance

    Valeant short seller on pharmacy alliance: It’s the ‘turd in the punch bowl’

    By Digital Assets Editor
  • J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, QuebecFinance

    Valeant’s accounting problems: It gets worse

    By Blockchain Reporter
  • Warren BuffettFinance

    Warren Buffett’s really bad week

    By Contributing Writer
  • Fortress Circling Stuyvesant Town Brings Sale CloserFinance

    What the $5 billion Stuyvesant Town deal says about the real estate market

    By Market Analyst
    Rankings
    • 100 Best Companies
    • Coins2Day 500
    • Global 500
    • Coins2Day 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Coins2Day Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Coins2Day Brand Studio
    • Coins2Day Analytics
    • Coins2Day Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Coins2Day
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.